Nuix Limited Overview
Nuix is an Australian-headquartered developer of forensic-grade unstructured-data intelligence software. Its core asset is a patented parallel-processing engine that ingests, normalises, indexes and enriches very large, messy data sets. The Annual Report 2026 cites up to 1.5TB per hour across more than 1,000 file types, with chain-of-custody defensibility. The company is migrating its installed base from a portfolio of point products (Workstation, Investigate, Discover, Automate/Rampiva, the Engine SDK) to a single browser-based platform, Nuix Neo, sold on a consumption/subscription basis with opt-in AI modules. Neo is now 30% of A$260.0m ACV. Customers are mainly government and law-enforcement agencies (40% of ACV), advisory firms, regulated corporates and law firms; more than 80% of ACV is generated outside Australia. After a disastrous 2020–21 post-IPO period, Nuix has rebuilt credibility. It returned to statutory profit in FY26 and won a clean sweep against ASIC at first instance. It is now repositioning from investigative tooling to an enterprise "governed data layer" for AI.
Company's own description (Annual Report 2026 / Appendix 4E)
In its FY26 Directors' Report, Nuix describes itself as a leading provider of investigative analytics and intelligence software. It says it lets organisations find meaningful insights from large volumes of unstructured data. The platform comprises a proprietary processing engine (the Nuix Engine) plus software applications, developed in-house since 2000 with input from long-standing government and private-sector customers. Nuix stresses that the platform works at a "forensic level", giving users a detailed, contextualised and legally defensible view of the data. The Annual Report 2026 sums up the mission as turning the world's most complex unstructured data into evidence, compliance insight and trustworthy AI. The company's long-running purpose statement is to be "a force for good by finding truth in the digital world."
Independent characterisation
Nuix is best understood as a specialist data-processing infrastructure vendor that sits at the evidentiary front end of high-stakes workflows. Its customers include digital forensics labs in police and intelligence agencies, regulators and integrity commissions, eDiscovery service providers and Big Four/advisory forensic practices, corporate legal and compliance functions, and law firms. Its differentiation lies in speed and scale of processing, breadth of file-format support, and defensibility (repeatable processing profiles, audit trails, court admissibility). It is less differentiated in front-end review UI and analytics, where Relativity, Everlaw, DISCO, Cellebrite, Magnet/Exterro and others compete heavily.
The FY24–FY26 strategy has two parts:
-
Platform consolidation. Nuix Neo bundles the Engine, automation/orchestration, a collaborative web investigation interface and APIs ("Neo Foundation"), then layers solution packs (Investigations, Legal Discovery, Data Privacy, Custom) and AI enablers on top.
-
Upward repositioning from an investigations tool to an enterprise unstructured-data governance layer that feeds AI. Management cites a multi-billion-dollar addressable market, more than 10,000 ideal-customer-profile (ICP) accounts, current penetration below 10%, and potential of A$500k+ ACV per ICP account.
Business and revenue model
| Dimension | FY26 disclosure (FY26 Results Presentation, appendix) |
|---|---|
| Software vs other revenue | Software revenue A$246.9m (93.8%); Other revenue A$16.4m (6.2%) |
| Subscription ACV share | 97% of total ACV (in line with FY25) |
| ACV by licence type | Software licence module 66%; Consumption 21%; Perpetual maintenance 10%; Perpetual licences 1%; Services (non-Advantage) 2% |
| Pricing mechanics | Module: annual or multi-year, per core or per user. Consumption: tiered cost per gigabyte processed or under management, often with minimum commitments. Perpetual: one-time per core, usually paired with maintenance. |
| Multi-year deals (% of revenue) | 35% in FY26 vs 27% in FY25. Multi-year on-premise subscriptions are largely recognised upfront under AASB 15, which makes revenue lumpier than ACV. |
| Customer concentration | Top 20 customers 32% of ACV; customers 21–100 34%; remainder 34%; no single customer above 3% of ACV |
| Customer tenure | More than 10 years: 43% of ACV; 5–10 years: 37%; under 5 years: 20% |
| ACV by industry (FY26) | Government 40%; Advisories 26%; Corporate 25%; Law firms 9% |
| Geographic exposure | More than 80% of ACV generated outside Australia; North America 54%, EMEA 27%, APAC 19% of ACV |
Value-chain position
Nuix sits upstream in the Electronic Discovery Reference Model (EDRM) and the digital-forensics workflow: identification, collection, processing and enrichment. Neo and Discover extend it into review, analysis and production. Linkurious (acquired April 2026) adds graph-based link analysis and decision intelligence for fraud, AML and investigations.
Nuix sells directly and through partners. eDiscovery service providers such as Lighthouse Document Technologies, Noticia and Lineal resell or host Nuix capacity. In FY26 COGS rose partly because of higher sales through partner channels.
End-markets
Law enforcement and national security: digital forensics, intelligence analysis, child-exploitation and organised-crime investigations.
Regulators and integrity agencies: misconduct, corruption and market-abuse investigations.
Legal and eDiscovery: litigation review, regulatory responses, FOI.
Corporate compliance, privacy and security: PII discovery and remediation, breach response, insider-risk investigations, records governance.
Financial crime (expanded via Linkurious): fraud rings, AML networks, beneficial-ownership analysis.
Strategy
Stated strategy (FY26 Results / Annual Report 2026 themes)
Management describes FY26 as a reset of how Nuix builds, positions, sells and embeds the Neo platform, moving "from feature selling to platform value." Five growth pillars underpin it:
-
Nuix Neo migration. A structured programme moving the component base to Neo, with typical ACV uplift of 30–50%.
-
Phase 1, Foundation & Intelligence (Dec 2025–Jan 2026): economic model validation, ICP definition, readiness assessment.
-
Phase 2, Build Migration Factory (Jan–Mar 2026): playbooks, regional deployment strategies, partner capability.
-
Phase 3, Execution at Scale (Apr 2026–FY30).
-
-
ICP upsell: deepening wallet share in high-value accounts with discrete AI modules and graph analytics.
-
New customers: account-based marketing aimed at the more than 10,000 ICP accounts (regulated large enterprises, 50TB+ of unstructured data, complex compliance, A$500k+ ACV potential).
-
Discover growth: a dedicated go-to-market team, EVP and R&D.
-
Partner and geographic expansion: channel-led reach.
Initiatives announced in the last 24 months
| Initiative | Date | Detail and targets |
|---|---|---|
| Nuix Neo migration programme | Launched Dec 2025 | Neo to become the majority of ACV in the medium term; 30% at FY26 |
| Linkurious acquisition | Announced 4 Dec 2025; closed 20 Apr 2026 | Graph intelligence; cross-sell into financial crime |
| Go-to-market realignment | Designed FY26; operational FY27 | Two regions (Americas, International) each under an EVP; Chief Customer Officer; Sales Enablement function; dedicated Discover team; Expert Services as revenue enabler; global partner leadership. Essentially cost-neutral apart from about A$4.5–5m of one-off restructuring costs in FY27. |
| Product & Technology unification | FY26 | CTO ownership, product operations, embedded design leadership |
| R&D Accelerator | Announced 24 Aug 2026 | One-off A$15m additional FY27 investment across Enterprise Integration & Connectivity, Agentic AI, Cloud Platform Acceleration, Unified UI/UX and Accelerated Innovation Cadence. Revenue benefit targeted from FY28. |
| AI strategy (external) | FY26 | Model-agnostic BYO AI, opt-in AI modules, auditability, sovereignty; MCP Server and Neo Agent on the roadmap |
| AI strategy (internal) | FY25–27 | NuixQ assistant (GA October 2025); AI Builders and AI Champion Network; Digital FTE (dFTE) programme with monthly dFTE targets per function from FY27. Stated aim is to scale capacity rather than cut headcount. |
| Reflect Reconciliation Action Plan | FY26 | Endorsed by Reconciliation Australia |
| Mandatory climate disclosures | From FY27 | Group 2 entity under ASRS; first reporting period year ending 30 Jun 2027 |
Strategic objectives and guidance track record
| Year | Objectives / guidance | Outcome |
|---|---|---|
| FY24 | About 10% ACV and revenue growth; revenue growth above cost growth | Exceeded: ACV +14% (+12% constant currency); revenue +20.9% |
| FY25 | About 15% ACV growth (constant currency); Neo rollout; revenue growth above cost growth; underlying cash flow positive | Missed on ACV (+8%); revenue flat; underlying cash flow A$20.1m positive |
| FY26 | ACV A$240–260m (excl. M&A), raised to A$252–272m including Linkurious; ACV growth driven by Neo; revenue growth above cost growth; underlying cash flow positive | Met: ACV A$260.0m, within range; all objectives delivered |
| FY27 | ACV A$285–300m (AUD/USD 0.70 assumption); Adjusted Management EBITDA similar to FY26 (about A$60m) after the A$15m R&D Accelerator; growth weighted to 2H | Pending |
The FY27 ACV guidance implies 9.6–15.4% reported growth. That includes a full year of Linkurious, already in the FY26 exit ACV, so it is effectively all organic plus FX.
Medium-term financial targets (margin or ACV targets beyond FY27) are n.p.d., apart from the qualitative goal of Neo becoming the majority of ACV in the medium term.
Products & Services
Nuix's catalogue is organised here by platform layer, since there are no statutory segments. Launch years reflect the earliest public reference found. "n.p.d." indicates pricing or version not disclosed.
Nuix Neo platform (strategic core)
| Offering | Description and capabilities | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Nuix Neo Foundation | Entry platform: patented binary processing engine, automation and orchestration, collaborative browser-based investigation interface, Neo platform APIs. Deployable on-premise or in customer cloud; Neo SaaS Foundation is on the roadmap. | All segments; positioned as the strategic land offer | FY24 launch; Foundation heavily promoted FY25–26 | Consumption-based subscription with on-demand scalability (Directors' Report FY26) |
| Neo Investigations | Solution pack for fraud, misconduct and incident investigations; used by law enforcement and regulators | Police, regulators, integrity agencies, corporate investigations | FY24–25 | Add-on solution; n.p.d. |
| Neo Legal Discovery | eDiscovery processing and review workflows on Neo; demand increasing in FY26, especially North America | Law firms, eDiscovery providers, corporate legal | FY25–26 | Add-on solution; n.p.d. |
| Neo Data Privacy | PII discovery and remediation; first Neo use case, built in FY23 for early-FY24 launch | Corporates, government (FOI, privacy compliance) | FY24 | Add-on solution; n.p.d. |
| Neo Custom Solutions | Customer-specific workflows built on the same platform | Large ICP accounts | FY26 | n.p.d. |
| AI enablers | BYO AI (customer-preferred LLM), Semantic Search, GenAI document review, GenAI summarisation and case chat, transcription, facial recognition, 500+ NLP models. Expanded in FY26; Neo 2.1 release with semantic search and UI upgrades was due from March 2026 (Morgan Stanley note, Feb 2026). | Existing Neo customers (about 20% had bought extra AI enablers by FY26) | FY24–26 | Priced as discrete, opt-in modules |
| Knowledge graph / graph visualisation (Linkurious technology) | Entity resolution and relationship mapping across people, organisations, accounts, transactions and communications; AML and fraud-ring use cases | Financial crime, law enforcement, intelligence | Acquired April 2026 | Add-on module (about 7% of Neo customers had purchased by FY26) |
| Neo Agent (Next) | User-initiated agentic AI workflows on uploaded data, with every action logged | Enterprise and government | Roadmap ("Next") | n.p.d. |
| MCP Server (Next) | Makes Neo callable from AI assistants and agentic surfaces through the Model Context Protocol | Enterprises building AI stacks | Roadmap ("Next") | n.p.d. |
| Nuix Advantage | Renewable consulting/engagement service, minimum 12-month term, counted in Subscription ACV | Strategic accounts | Ongoing | Subscription |
About 60% of Neo customers had purchased the AI-enriched solutions library by FY26 (FY26 Results Presentation, slide 23). The typical ACV uplift when a component customer migrates to full Neo is 30–50%.
Component (legacy / standalone) products
| Product | Description | Target customer | Status | Pricing |
|---|---|---|---|---|
| Nuix Engine | Core parallel-processing engine; also licensed via SDK/OEM to partners | ISVs, service providers, government | Since 2000s; embedded in Neo | Per core / OEM; n.p.d. |
| Nuix Workstation | Desktop forensic processing and analysis application | Digital forensics labs | Mature; migrating to Neo | Module (per core/user) |
| Nuix Investigate | Browser-based collaborative review for investigators | Law enforcement, regulators | Mature; migrating to Neo | Module |
| Nuix Automate / Rampiva | Automation and orchestration of processing pipelines (24/7 queues). Rampiva technology was acquired and integrated, and the prior Automate product's amortisation was accelerated in FY25. | Labs with high case volumes | Integrated into Neo Foundation | Module |
| Nuix ECC / collection tools | Enterprise collection (identify and collect stage) | Corporates, service providers | Mature | Module; n.p.d. |
| Other legacy lines (e.g., Data Finder, Adaptive Security endpoint, Enrich) | Historical products for data discovery and endpoint security | Various | Current commercial status not confirmed in FY26 filings | n.p.d. |
Nuix Discover (separately managed franchise from FY27)
| Attribute | Detail |
|---|---|
| Description | End-to-end eDiscovery review platform with AI relevance ranking, native processing, email threading, multitenancy, audio/video review (roadmap); derived from the Ringtail platform |
| Deployment | On-premise, customer cloud, Nuix-hosted SaaS (AWS regions: Canada, Germany, Australia, UK, US, Brazil), or partner-hosted SaaS (e.g., Noticia's Canadian data centre) |
| FY26 performance | On-premise growth offset by a SaaS decline, driven by the loss of one large SaaS contract (an APAC law-firm account); net -A$2.7m ACV |
| FY26 wins cited | Global commodities trader replacing a competitor; major APAC bank choosing on-premise Discover over a key competitor; Canadian law firm migrating to Discover SaaS. Noticia case study cites a 75% eDiscovery cost reduction for a major Canadian law firm. |
| Strategy | New EVP Discover reporting to the CEO, dedicated sales team, R&D Accelerator funding for UX and agentic features |
| Pricing | SaaS consumption (per GB) or module licence; n.p.d. |
Linkurious (acquired 20 April 2026)
| Attribute | Detail |
|---|---|
| Company | Linkurious SAS, Paris; founded 2013; CEO Sébastien Heymann (at signing) |
| Offering | Graph-powered AI decision-intelligence and visualisation platform for exploring graph data, detecting patterns of interest and investigating alerts. Uses include AML, fraud, financial crime, intelligence analysis and cybersecurity. |
| Customers | North America, Europe and APAC, including major financial institutions and regulators, with some joint Nuix customers |
| Financials | ACV about €7m (about A$12m) at June 2025; positive EBITDA and operating cash flow in CY2024. FY26 contribution: ACV A$12.0m (run-rate), revenue A$3.8m and EBITDA A$2.0m over 72 days. |
| Go-to-market | Sold standalone and as a Neo add-on; full team and Paris office retained |
Services and internal platforms
Expert Services: professional services, repositioned in FY27 as a revenue-enabling capability.
Training and certification: offered; pricing not disclosed.
NuixQ: internal AI assistant, not a commercial product. Built on Anthropic technology in partnership with Amazon and generally available since October 2025. It reached a 92% adoption rate among active users and 79,523 automated action invocations by July 2026 (Annual Report 2026).
Financial Narrative
All A$m unless stated. Sources: FY26 Results Presentation (5-year charts and appendix), FY26/FY25/FY24/FY23 Appendix 4E and results releases, Annual Report 2023. Items marked "derived" are calculated from disclosed figures.
Income statement — chartable core
Note: the FY2022 growth cells show 0 as a placeholder because FY21 comparables are on a different (pro forma) basis. Treat them as not applicable. FY22 statutory NPAT of -A$22.791m is from the FY23 Appendix 4E comparative.
Revenue CAGR FY22–FY26 (derived): 14.7%. ACV CAGR FY22–FY26 (derived): 12.6%.
Income statement — items with partial history (non-chart)
FY24 underlying EBITDA of A$64.4m (+38.7%) is per Capital Brief, citing the FY24 release. FY22–23 PBT is from the FY23 Results Presentation (statutory). Gross profit is not separately disclosed in the earlier-year excerpts reviewed.
Balance sheet
FY24 net cash is approximated by reported cash on hand of about A$38m (Capital Brief, Aug 2024); treat it as approximate. FY26 net cash equals cash A$69.9m less debt A$20.1m.
30 June 2026 vs 31 December 2025 balance sheet (FY26 Results Presentation, appendix):
FY25 year-end total equity was about A$290.8m (InvestSMART aggregator; secondary). The goodwill vs other intangibles split is n.p.d. in the excerpts reviewed. The current/non-current classification of contract assets was not disclosed in the excerpts, so working capital and the current ratio cannot be computed precisely (n.p.d.).
Debt facility: A$50m HSBC multicurrency revolving facility, upsized in FY26. A$20.0m was drawn for Linkurious and A$1.337m used for bank guarantees at 30 June 2026 (Annual Report 2026). Maturity date n.p.d.
Cash flow
FY26 free-cash-flow conversion (underlying FCF ÷ Adjusted Management EBITDA) was 85% (FY26 Results Presentation, slide 19).
Trend commentary
Revenue and ACV. FY22 marked the post-IPO trough. ACV fell slightly as new business stalled, and revenue was depressed by fewer multi-year deals. FY23–FY24 saw a recovery under Rubinsztein, with ACV growing about 14% a year and revenue about 20% a year. NDR peaked at 112.9% in FY24.
FY25 was an inflection downward. Revenue was flat (+0.4%) because multi-year deal timing fell to 27% of revenue. ACV grew only 8% against a ~15% constant-currency objective, as churn rose to 7.1% and downsell hit legacy components. FY26 re-accelerated: revenue +18.8% (+17.1% organic, +20.3% organic constant currency), driven by multi-year renewals and Neo. Organic ACV growth of 8.6% (11.1% constant currency) is respectable rather than spectacular. Neo's +A$50.4m was partly cannibalisation, given the -A$28.2m component movement.
Profitability. Adjusted Management EBITDA moved from -A$13.2m (FY22) to A$59.8m (FY26), with margin up about 31 percentage points over four years. Drivers were R&D discipline (total R&D roughly flat in dollars while revenue grew 73%) and G&A restraint. Statutory NPAT is far more volatile. It is weighed down by heavy D&A on previously capitalised software (A$48.7m in FY26) and recurring legacy legal costs of A$8.5–13.0m a year. The FY26 NPAT also benefited from a A$2.9m tax benefit following a favourable tax ruling.
Accounting quality. The capitalised share of R&D fell from 73% (FY22) to about 40% (FY25–26). This is a material conservatism improvement: EBITDA is now less flattered by capitalisation. It also means statutory D&A should keep trending down as the older capitalised base amortises out, a tailwind to future EBIT.
Cash. FY26 cash generation is the standout metric. Underlying cash flow rose 154% to A$51.0m and FCF reached A$37.4m. This is after funding all development spend internally, and despite A$9.3m of net legal payments. Contract assets (A$75.0m) and receivables (A$66.7m) rose sharply, reflecting instalment-billed multi-year deals. Monitor this as a quality-of-revenue indicator.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Statutory revenue (AUD Mn) | 152.3 | 182.5 | 220.6 | 221.5 | 263.2 |
Revenue growth YoY (%) | 0 | 19.8 | 20.9 | 0.4 | 18.8 |
ACV (AUD Mn) | 162.0 | 185.5 | 211.5 | 228.4 | 260.0 |
ACV growth YoY (%) | 0 | 14.5 | 14.0 | 8.0 | 13.9 |
Adjusted Management EBITDA, formerly Cash EBITDA (AUD Mn) | -13.2 | 6.6 | 29.9 | 37.2 | 59.8 |
Adjusted Management EBITDA margin (%) | -8.7 | 3.6 | 13.6 | 16.8 | 22.7 |
Statutory EBITDA (AUD Mn; FY22 derived from FY23 +189.2%) | 12.1 | 34.9 | 55.9 | 47.6 | 66.9 |
Statutory EBITDA margin (%, derived) | 7.9 | 19.1 | 25.3 | 21.5 | 25.4 |
Statutory NPAT (AUD Mn) | -22.8 | -5.6 | 5.0 | -9.2 | 16.4 |
Net margin (%, derived) | -15.0 | -3.1 | 2.3 | -4.2 | 6.2 |
Multi-year deals share of revenue (%) | 40 | 30 | 31 | 27 | 35 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY22–FY26)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Gross profit (AUD Mn) | n.p.d. | n.p.d. | n.p.d. | 199.7 | 236.0 |
Gross margin (%) | n.p.d. | n.p.d. | n.p.d. | 90.1 | 89.7 |
Underlying EBITDA (AUD Mn) | n.p.d. | n.p.d. | 64.4 | 60.0 | 83.2 |
Net non-operational legal costs (AUD Mn) | n.p.d. | n.p.d. | 8.5 | 10.6 | 13.0 |
Restructuring costs (AUD Mn) | n.p.d. | n.p.d. | n.p.d. | 1.7 | 0.5 |
Acquisition costs (AUD Mn) | 0 | 0 | 0 | 0 | 2.8 |
Depreciation & amortisation (AUD Mn) | n.p.d. | n.p.d. | n.p.d. | 55.2 | 48.7 |
EBIT / operating income (AUD Mn) | n.p.d. | n.p.d. | n.p.d. | -7.6 | 18.2 |
Profit before tax (AUD Mn) | -24.1 | -5.3 | n.p.d. | -9.0 | 13.5 |
Income tax benefit/(expense) (AUD Mn) | n.p.d. | n.p.d. | n.p.d. | -0.2 | 2.9 |
EPS basic (A$ cents) | n.p.d. | n.p.d. | n.p.d. | n.p.d. | about 4.9 (derived: NPAT ÷ about 335m average shares) |
Dividends per share | 0 | 0 | 0 | 0 | 0 |
Income Statement and Margin Analysis (%) — Total R&D spend
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total R&D spend (AUD Mn) | 58.3 | 60.0 | 53.0 | 54.8 | 57.8 |
Capitalised R&D (AUD Mn) | 42.4 | 39.8 | 34.5 | 22.7 | 23.4 |
Expensed R&D (AUD Mn) | 15.9 | 20.2 | 18.5 | 32.1 | 34.3 |
R&D as % of revenue | 38 | 33 | 24 | 25 | 22 |
Capitalised share of R&D (%, derived) | 73 | 66 | 65 | 41 | 40 |
Key Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Net cash (AUD Mn) | 46.8 | 29.6 | 38.0 | 40.0 | 49.9 |
Balance Sheet
| Line item (AUD Mn) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Cash and cash equivalents | 57.8 | 69.9 |
Trade and other receivables | 51.0 | 66.7 |
Contract assets | 61.9 | 75.0 |
Other current assets | 10.4 | 13.4 |
Property, plant & equipment | 3.0 | 3.0 |
Intangibles (goodwill plus capitalised software plus acquired intangibles) | 209.5 | 229.9 |
Deferred tax and lease assets | 28.9 | 25.8 |
Total assets | 422.4 | 483.8 |
Trade and other payables | 23.0 | 37.4 |
Deferred tax and lease liabilities | 23.4 | 25.3 |
Deferred revenue | 67.5 | 68.3 |
Debt (HSBC revolver; short/long split n.p.d.) | 0.0 | 20.1 |
Provisions | 4.4 | 6.1 |
Other liabilities (includes Linkurious deferred/contingent consideration) | 1.5 | 13.5 |
Total liabilities | 119.8 | 170.6 |
Issued capital | 380.8 | 393.7 |
Reserves | -141.4 | -149.1 |
Retained earnings | 63.2 | 68.6 |
Total equity | 302.6 | 313.1 |
Cash Flow
| Metric | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
Net operating cash flow (AUD Mn; secondary, InvestSMART) | 35.3 | 50.3 | 26.9 | n.p.d. |
Net investing cash flow (AUD Mn; secondary) | -48 | -38 | -23 | n.p.d. |
Underlying cash flow, before non-operational legal, restructuring and M&A (AUD Mn) | n.p.d. | n.p.d. | 20.1 | 51.0 |
Overall free cash flow (AUD Mn) | n.p.d. | n.p.d. | 4.0 | 37.4 |
Capitalised development (cash capex proxy) (AUD Mn) | 39.8 | 34.5 | 22.7 | 23.4 |
Net non-operational legal payments (AUD Mn) | n.p.d. | n.p.d. | 14.8 | 9.3 |
Dividends paid | 0 | 0 | 0 | 0 |
Share buybacks | 0 | 0 | 0 | 0 |
Financial Ratios (x)
| Ratio | FY26 value | Basis |
|---|---|---|
ROE | about 5.4% | NPAT 16.4 ÷ average equity (290.8 FY25 secondary; 313.1 FY26) |
ROA | about 3.4% | NPAT ÷ closing total assets 483.8 (FY25 total assets n.p.d.) |
ROIC | about 4–5% | EBIT 18.2 × (1 – 30%) ÷ (equity 313.1 + debt 20.1 – cash 69.9); approximate, given the tax benefit distortion |
Current ratio | n.p.d. | Current/non-current split not available in the excerpts |
Debt / equity | 0.06x | 20.1 ÷ 313.1 |
Net debt / EBITDA | Net cash (-0.7x statutory EBITDA) | -49.9 ÷ 66.9 |
Interest coverage (EBIT / finance costs) | about 9.1x | 18.2 ÷ 2.0 |
Asset turnover | 0.54x | Revenue 263.2 ÷ total assets 483.8 |
Cash conversion cycle | n.p.d. | Receivables days about 92 (derived: 66.7 ÷ 263.2 × 365), inflated by late-year deal closures |
Revenue by Region
| Region (ACV, AUD Mn) | FY2025 | FY2026 |
|---|---|---|
North America ACV (AUD Mn) | 123.3 | 141.3 |
EMEA ACV (AUD Mn) | 57.8 | 71.0 |
Asia Pacific ACV (AUD Mn) | 47.4 | 47.8 |
Total ACV (AUD Mn) | 228.4 | 260.0 |
Geographic Revenue
| Region | Share of FY26 ACV | Reported growth incl. Linkurious | Organic growth | Organic constant-currency growth | Key drivers (FY26 Results Presentation, slide 14) |
|---|---|---|---|---|---|
North America | 54% | 14.6% | 12.1% | 16.4% | Strong government agency sales, Neo adoption, stronger corporate sales, Neo Foundation and Legal solution |
EMEA | 27% | 22.9% | 8.4% | 8.3% | Neo Investigations across law enforcement and regulators; strong new-logo acquisition in Central Europe; Linkurious (Paris) adds disproportionately |
Asia Pacific | 19% | 0.9% | -0.2% | 0.6% | Government wins and Neo adoption offset by loss of a key law-firm account (Discover SaaS) |
Share Price History
| Date | Price (AUD) | Note |
|---|---|---|
4 Dec 2020 | 5.31 | IPO price |
Jan 2021 |
| All-time high (Shine Lawyers) |
31 May 2021 | <3.00 | After downgrades |
6 Feb 2023 | ~0.90 | Pre-Sheehy judgment (market cap about A$287m) |
7 Feb 2023 | ~1.19 | After Sheehy dismissal |
Mar 2025 | ~3.29–3.37 | Director purchases |
52-week high (to Jul 2026) | 3.35 | Halo Technologies |
2 Jan 2026 (approx.) | 1.81 | Start of CY2026 (InvestSMART) |
2026 low | 1.07 | CY2026 low (InvestSMART) |
4 May 2026 | 1.545 | CEO appointment day |
30 Jul 2026 | 1.24 | Market cap about A$420m (Halo) |
21 Aug 2026 | 1.425 | Pre-FY26 result close |
24 Aug 2026 | ~1.80–1.86 | FY26 result day, up 26–30% |
Early Sep 2026 | ~1.90 | Latest verified price (InvestSMART) |
Valuation Multiples
| Multiple | Nuix (FY26 actual) | Nuix (FY27 guidance-based) | Notes |
|---|---|---|---|
P/E (statutory) | about 39x | n.p.d. | FY26 NPAT A$16.4m includes a A$2.9m tax benefit |
EV / Adjusted Management EBITDA | about 9.9x | about 9.9x | FY27 Adjusted EBITDA guided similar to FY26 |
EV / Statutory EBITDA | about 8.9x | n.p.d. | — |
EV / Revenue | about 2.3x | n.p.d. | — |
EV / ACV | about 2.3x | about 2.0–2.1x | FY27 ACV guidance A$285–300m |
P / Book | about 2.1x | — | Book equity A$313.1m |
Dividend yield | 0% | 0% | No dividends since IPO |
Analyst Ratings & Targets
| Broker | Date | Rating | Target (AUD) |
|---|---|---|---|
Morgan Stanley | 24 Feb 2026 | Overweight | 3.75 (cut from 4.35) |
Shaw and Partners | 6 Feb 2026 | Coverage ceased | — |
Consensus | — | 8 analysts cover the stock (Simply Wall St, Apr 2026) | Consensus figures n.p.d. |
Analyst Conclusions
Management guidance (FY27)
| Item | Guidance |
|---|---|
| ACV | A$285–300m (+9.6% to +15.4%), at AUD/USD 0.70 |
| Adjusted Management EBITDA | Similar to FY26's A$59.8m, including the one-off A$15m R&D Accelerator. Implies about A$75m of underlying run-rate before the Accelerator (derived). |
| Phasing | Growth weighted to the second half, as in prior years |
| Drivers | Neo migration at established cadence; renewal book; upsell attach rates; new customers |
| One-offs | About A$4.5–5m restructuring cost in FY27, excluded from Adjusted Management EBITDA |
Consensus FY27/FY28 forecasts are n.p.d. in the sources reviewed.
Bull case
-
The migration flywheel is underpriced. About A$169.5m of component and Discover ACV remains (derived). At a 30–50% uplift, full migration could add roughly A$50–85m of ACV over FY27–FY30 before any new logos. That is at an EV/ACV multiple near 2x.
-
Operating leverage is proven and should resume. The margin rose about 6 percentage points in FY26. Once the A$15m Accelerator rolls off in FY28, Adjusted Management EBITDA could step up sharply on 10–15% ACV growth with flat-to-modest cost growth. FCF conversion of 85% supports a cash-yield valuation.
-
The legal overhang is shrinking. The directors' ASIC exoneration is final. The company-level appeal has to overturn a comprehensive first-instance judgment. A favourable class-action judgment would remove the last major discount factor.
Bear case
-
Organic growth is mediocre. Organic ACV grew 8.6% (11.1% constant currency) and NDR has fallen three years running (112.9% to 105.2%). Neo growth may largely be repricing the existing base rather than winning share.
-
Class-action tail risk. An adverse Victorian judgment could create a liability that is material relative to a market cap of about A$640m. The A$10m insurance retention increases Nuix's net share of any loss.
-
AI commoditisation and competition. Generative AI and Microsoft Purview could compress pricing for processing and review. FY26 already showed downsell from competitive displacement and pricing decisions, and the loss of a large Discover SaaS account.
Key catalysts and monitorables (next 12 months)
November 2026 AGM: trading update: 1Q27 ACV trajectory against A$285–300m guidance; new NED appointment.
Victorian class-action judgment: (timing unknown): the most important binary event.
ASIC appeal: hearing date and outcome.
1H27 result (about February 2027): - Neo ACV (base A$78.5m; watch for above A$100m).
-
NDR recovery above 105%.
-
Churn back toward about 5%.
-
Discover stabilisation.
-
Linkurious earnout trajectory.
R&D Accelerator delivery: Neo SaaS, MCP Server and Neo Agent releases; Discover UX refresh.
Macquarie intentions: any sell-down, block trade or strategic review, especially with a nominee now on the board.
Capital allocation: further tuck-in M&A using A$30m of undrawn facility and net cash; any first dividend or buyback discussion (unlikely near term).
FX: AUD/USD versus the 0.70 guidance assumption.
Analyst verdict
Nuix in October 2026 is a materially better business than the one that collapsed after its 2020 float. It is still not a fully de-risked one.
The FY26 numbers are genuinely good. Revenue grew 18.8% to A$263.2m. Adjusted Management EBITDA rose 60% to A$59.8m at a 22.7% margin, and statutory profit of A$16.4m was earned on more conservative capitalisation practices. Underlying cash flow of A$51.0m funded all development spend and the Linkurious deal, and still lifted net cash to A$49.9m. Nuix Neo has moved from concept to 30% of ACV in under three years, and its migration economics (30–50% uplift) give visible, largely self-generated growth.
The caveats are equally clear. Strip out Linkurious and FX, and organic ACV growth is about 11%. NDR has fallen for two years and churn is above FY24 levels. Much of Neo's growth is migration of the existing base rather than share gain. Management is also asking investors to accept a flat EBITDA year in FY27 to fund a one-off A$15m R&D push whose payoff is pencilled in for FY28. That request is easier to grant to a new CEO with a clean first-year record than to the Nuix of 2021, but it remains a request.
The legal cloud has thinned rather than lifted. The ASIC win was emphatic, yet the company-level appeal and the reserved class-action judgment keep a tail risk in the valuation, made heavier by the A$10m insurance retention.
At roughly 2x EV/ACV and about 10x Adjusted EBITDA, with net cash, the stock already discounts a lot of this risk. Our synthesis is a constructive but event-driven stance. The investment case hinges on Neo sustaining A$40–50m of net new ACV a year, NDR recovering above 108%, and a non-catastrophic class-action outcome. Delivery on those three would warrant a material re-rating. Failure on any one would likely keep the shares range-bound.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Independence | Background (Annual Report 2026) | Shares held |
|---|---|---|---|---|---|
Robert Mactier | Non-Executive Chairman | Director Oct 2021; Chair Feb 2023 | Independent | NED at Iress (since Oct 2024) and Kinetic IT; consultant to UBS Australia advisory/capital markets (since 2007); former Chair of ALE Property Group and WPP AUNZ; former NED of Melco Resorts; early career at KPMG, then Ord Minnett, E.L. & C. Baillieu, Citigroup. BEc (Sydney). | 300,000 (bought 75,000 at A$1.855 on 5 Mar 2026) |
John Ruthven | CEO & Managing Director | Interim CEO 3 Nov 2025; CEO and director 4 May 2026 | Executive | Former CEO & MD of Integrated Research (ASX: IRI) 2019–2024; senior roles at TechnologyOne, SAP (ANZ President/MD), Zuora (SVP International Sales), CA Technologies. Undergraduate studies at Avondale College (MarketScreener); B.Ed, MAICD (Simply Wall St). Brisbane-based. | Nil per Annual Report 2026 |
Sir Iain Lobban KCMG CB | Non-Executive Director | Adviser Oct 2018; NED Nov 2020 | Independent | Director of GCHQ 2008–2014; adviser on Australia's 2015 Cyber Security Strategy and 2017 Intelligence Review. BA (Leeds). Retiring at the November 2026 AGM; will remain an adviser. | Nil |
Jacqueline Korhonen | Non-Executive Director | Oct 2021 | Independent | 23 years at IBM; former CEO of Infosys ANZ and SMS Management & Technology; NED at MyState Bank and Bapcor; formerly CASA board (2023–Feb 2026). BSc/BE (Hons) Sydney; FAICD. | 32,258 |
Alan Cameron AO | Non-Executive Director | Jan 2023 | Independent | Former Chair of ASC/ASIC; former Commonwealth Ombudsman; former managing partner of the firm now Ashurst Perkins Coie; former PEXA Chair; former NSW Law Reform Commission Chair. BA, LLM (Sydney). | 23,800 |
Sara Watts | Non-Executive Director | Jan 2023 | Independent | Former CFO of IBM ANZ; former Vice-Principal Operations, University of Sydney; NED at Syrah Resources; Sydney Opera House Trust; NACC audit committee. FCPA, FAICD; MBA. | 12,158 (bought Mar 2025 at A$3.29) |
Rachel Barger | Non-Executive Director | 1 Mar 2026 | Independent | Chief Revenue Officer at Epicor; former President Go-To-Market at UKG; SVP roles at Cisco; President SE Asia and APAC COO at SAP; former NED of CSG Systems. MBA (AGSM); BChemEng (Delaware). US-based. | Nil |
Edward (Ted) Pretty | Non-Executive Director | 1 Mar 2026 | Non-independent (Macquarie Capital nominee) | Former Telstra Group MD Technology & Product; Chair of Firmus and Dubber; former Chair of NextDC, RP Data, Fujitsu Australia, Tech Mahindra ANZ. LLB (Hons)/BA (Econ), Macquarie University. | Nil |
Executive Leadership Team
| Name | Title | Tenure / notes | Disclosed compensation |
|---|---|---|---|
John Ruthven | CEO & MD | Interim from 3 Nov 2025; permanent from 4 May 2026 | Fixed remuneration A$900,000 a year, plus STIP and LTIP effective 1 Jul 2026, Brisbane–Sydney accommodation and travel support, and a possible discretionary bonus for the interim period (ASX release, 4 May 2026). FY26 statutory total: see Remuneration Report (n.p.d. in excerpts reviewed). |
Peter McClelland | Chief Financial Officer | About 1.4 years as of Apr 2026 (Simply Wall St) | A$619k (Simply Wall St; likely FY25 partial year; secondary) |
Alexis Rouch | Chief Technology Officer; owns unified Product & Technology from FY26 | About 2.3 years | n.p.d. |
Ilona Meyer | General Counsel and EVP Discover (from 6 Jul 2026); Company Secretary until 6 Jul 2026 | Joined Aug 2022; ex-Boehringer Ingelheim, ResMed, Medtronic, 3M | n.p.d. |
Michael Smith | EVP Americas | About 3.8 years | A$1.22m (Simply Wall St; secondary) |
Warren Brugger | EVP APAC & Global Alliances (role likely evolving under the FY27 International structure) | About 3.4 years | A$0.905m (Simply Wall St; secondary) |
Sarah Nichols | Chief Strategy & Transformation Officer | About 1.3 years | n.p.d. |
Jacqui Levings | Chief People Officer | About 3.3 years | n.p.d. |
Nicholas Vesic | Company Secretary (from 6 Jul 2026) | Joined Jun 2024; ex-Macquarie Technology Group, WiseTech, King & Wood Mallesons | n.p.d. |
Brett Dimon | Head of Investor Relations & Sustainability | Long-serving IR head | n.p.d. |
Chief Customer Officer; EVP International | New FY27 roles | Named in FY26 presentation; incumbents n.p.d. | n.p.d. |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Late 2024 (approx.) | Peter McClelland becomes CFO | Exact date n.p.d. |
Late Oct 2025 | Rubinsztein to step down effective 31 Oct 2025 | Board said Nuix was stable and it was time for new leadership for the next growth phase, following the FY25 ACV miss |
3 Nov 2025 | Ruthven interim CEO | Global search launched |
4 May 2026 | Ruthven permanent CEO & MD | Unanimous board decision after the global search |
FY26 | Product and Technology unified under the CTO | Part of the strategic reset |
6 Jul 2026 | Meyer to EVP Discover; Vesic Company Secretary; group restructure communicated | FY27 go-to-market realignment |
Major Shareholders
| Holder | Shares | Stake | Source / date |
|---|---|---|---|
Macquarie Group Limited and controlled bodies | 96,306,830 | 29.76% | InvestSMART substantial holder register (latest notice). Market Index shows 95.65m (29.75%) as at 5 Sep 2023. |
Australian Ethical Investment Ltd | 16,875,771 at initial notice | 5.10% initial; changes lodged 26 Aug 2026 and 2 Sep 2026 | TipRanks/ASX; current level n.p.d. |
ECP Asset Management / EC Pohl & Co | n.p.d. | 5.22% at notice (date not captured) | TipRanks/ASX |
Unidentified holder | n.p.d. | Ceased to be substantial holder, 1 Sep 2026 | InvestSMART announcements list |
Competitive Landscape
Competitors by Segment
| Domain | Competitor | Ownership | Positioning vs Nuix |
|---|---|---|---|
eDiscovery review / legal | Relativity (RelativityOne) | Private (Silver Lake) | Dominant legal-review platform with a large partner ecosystem; Nuix competes on processing and in the Discover segment |
eDiscovery (cloud-native) | Everlaw | Private | Cloud-native review with strong mid-market law-firm traction; pressure on Discover SaaS |
eDiscovery (cloud-native) | DISCO (CS Disco) | NYSE: LAW | AI-forward legal SaaS; smaller and loss-making |
eDiscovery / forensics | Exterro (incl. FTK / AccessData) | Private (Leeds Equity) | Directly competes in forensics processing and legal governance |
eDiscovery / review | Reveal (incl. Brainspace) | Private | AI-led review; competes in advisory and service-provider channels |
Digital forensics (mobile / law enforcement) | Cellebrite | NASDAQ: CLBT | Leader in mobile extraction and investigations software for law enforcement; overlaps with Neo Investigations |
Digital forensics | Magnet Forensics (Magnet AXIOM / Griffeye) | Private (Thoma Bravo since 2023) | Strong in law-enforcement forensic analysis; overlaps with Workstation and Investigate |
Enterprise information / eDiscovery | OpenText (EnCase, Axcelerate) | NASDAQ/TSX: OTEX | Broad suite; legacy EnCase installed base competes in forensics |
Compliance / privacy | Microsoft Purview (eDiscovery Premium) | Microsoft | "Good-enough" native M365 eDiscovery is a structural threat at the low end |
Data privacy / DSPM | BigID, Varonis, Securiti | Private / NASDAQ: VRNS | Compete with Neo Data Privacy and enterprise data-governance positioning |
Intelligence / link analysis | Palantir (Gotham), i2 Analyst's Notebook (Harris), Quantexa, Cambridge Intelligence, Neo4j | Mixed | Compete with Linkurious and graph intelligence |
Peer Comparison FY2026
| Metric | Nuix (FY26, A$) | Cellebrite (FY2024, US$) | DISCO (FY2024, US$) | OpenText (FY2025, US$) |
|---|---|---|---|---|
Revenue | A$263.2m | about US$401m | about US$145m | about US$5.2bn |
Revenue growth | 18.8% | about 25% | about 5% | Negative (divestitures) |
Profitability | Adj. Mgmt EBITDA margin 22.7%; NPAT margin 6.2% | Adjusted EBITDA margin about 20%+ | Adjusted EBITDA negative | Adjusted EBITDA margin about 35% |
R&D intensity | 22% of revenue (total incl. capitalised) | n.p.d. here | n.p.d. here | about 13–15% |
Recent Developments
--



